A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer Meeting Abstract

cited authors

  • Alvarez-Secord, A., Berchuck, A., Higgins, R., Nycum, L., Kohler, M., Puls, L., Holloway, R., Lewandowski, G., Valea, F., Havrilesky, L.

authors

Publication Date

  • March 1, 2010

webpage

published in

category

start page

  • S3

end page

  • S3

volume

  • 116

issue

  • 3

WoS Citations

  • 0

WoS References

  • 0